The Eukaryotic Pathogens Innovation Center (EPIC) at Clemson is an interdisciplinary research cooperative founded in 2013 to study the organisms responsible for infectious diseases that threaten the health of billions of people worldwide. EPIC looks at both parasitic and fungal pathogens, and over the past decade it has received more than $50 million in federal funding. EPIC researchers work at the forefront of biomedical research studying the eukaryotic pathogens that cause some of the most devastating and intractable human diseases, including malaria, amoebic dysentery, sleeping sickness, Chagas disease and fungal meningitis.
